Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

211 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Scaling up and implementing the digital Survivorship Passport tool in routine clinical care - The European multidisciplinary PanCareSurPass project.
Filbert AL, Kremer L, Ladenstein R, Chronaki C, Degelsegger-Márquez A, van der Pal H, Bardi E, Uyttebroeck A, Langer T, Muraca M, Nieto AC, Rascon J, Bagnasco F, Beyer S, Te Dorsthorst J, Essiaf S, Galan AO, Kienesberger A, O'Brien K, Palau MC, Pluijm SMF, di Profio S, Saraceno D, Schneider C, Schreier G, Trinkūnas J, Zamberlan I, Grabow D, Haupt R; PanCareSurPass consortium. Filbert AL, et al. Among authors: van der pal h. Eur J Cancer. 2024 May;202:114029. doi: 10.1016/j.ejca.2024.114029. Epub 2024 Mar 19. Eur J Cancer. 2024. PMID: 38513384 Free article.
Barriers and facilitators to implementation of the interoperable Survivorship Passport (SurPass) v2.0 in 6 European countries: a PanCareSurPass online survey study.
van den Oever SR, de Beijer IAE, Kremer LCM, Alfes M, Balaguer J, Bardi E, Nieto AC, Cangioli G, Charalambous E, Chronaki C, Costa T, Degelsegger A, Düster V, Filbert AL, Grabow D, Gredinger G, Gsell H, Haupt R, van Helvoirt M, Ladenstein R, Langer T, Laschkolnig A, Muraca M, Rascon J, Schreier G, Tomasikova Z, Tormo MT, Trinkunas J, Trollip J, Trunner K, Uyttebroeck A, van der Pal HJH, Pluijm SMF; PanCareSurPass consortium. van den Oever SR, et al. Among authors: van helvoirt m, van der pal hjh. J Cancer Surviv. 2024 Jun;18(3):928-940. doi: 10.1007/s11764-023-01335-y. Epub 2023 Feb 20. J Cancer Surviv. 2024. PMID: 36808389
European recommendations for short-term surveillance of health problems in childhood, adolescent and young adult cancer survivors from the end of treatment to 5 years after diagnosis: a PanCare guideline.
de Beijer IAE, Skinner R, Haupt R, Grabow D, Bardi E, Beccaria A, Nieto AC, Essiaf S, Filbert AL, Gsell H, Kienesberger A, Langer T, McColgan P, Muraca M, Rascon J, Tallone R, Tomasikova Z, Uyttebroeck A, Kremer LCM, van der Pal HJH, Mulder RL; PanCareSurPass consortium. de Beijer IAE, et al. Among authors: van der pal hjh. J Cancer Surviv. 2023 Dec 4. doi: 10.1007/s11764-023-01493-z. Online ahead of print. J Cancer Surviv. 2023. PMID: 38048011
Prevalence and determinants of metabolic syndrome in 2338 childhood cancer survivors: A Dutch Childhood Cancer Survivor LATER 2 study.
Bolier M, de Winter DTC, Pluimakers VG, Fiocco M, van den Berg SAA, Bresters D, van Dulmen-den Broeder E, van der Heiden-van der Loo M, Höfer I, Janssens GO, Kremer LCM, Loonen JJ, Louwerens M, van der Pal HJ, Pluijm SMF, Tissing WJE, van Santen HM, de Vries ACH, van der Lely AJ, van den Heuvel-Eibrink MM, Neggers SJCMM. Bolier M, et al. Among authors: van der pal hj. Cancer. 2025 Jan 1;131(1):e35681. doi: 10.1002/cncr.35681. Cancer. 2025. PMID: 39748458
Long-term risk and characteristics of cerebrovascular events after upper body radiotherapy among childhood cancer survivors in the DCCSS-LATER cohort.
Verbruggen LC, Kok JL, Kremer LCM, Janssens GO, Nederkoorn PJ, Penson A, Versluijs AB, de Vries ACH, Reedijk AMJ, Bresters D, Hoving EW, van Dulmen-den Broeder E, Loonen JJ, de Bont J, Wilbers J, Louwerens M, van der Heiden-van der Loo M, van den Heuvel-Eibrink MM, Pluijm SMF, Neggers SJCMM, Tissing WJE, Roos YBWEM, Ronckers CM, Teepen JC, van der Pal HJH; DCCSS‐LATER consortium. Verbruggen LC, et al. Among authors: van der pal hjh. Int J Cancer. 2024 Dec 16. doi: 10.1002/ijc.35275. Online ahead of print. Int J Cancer. 2024. PMID: 39686528
Prevalence and determinants of dyslipidemia in 2338 Dutch childhood cancer survivors: a DCCS-LATER 2 study.
Bolier M, Pluimakers VG, de Winter DTC, Fiocco M, van den Berg SAA, Bresters D, van Dulmen-den Broeder E, van der Heiden-van der Loo M, Höfer I, Janssens GO, Kremer LCM, Loonen JJ, Louwerens M, van der Pal HJ, Pluijm SMF, Tissing WJE, van Santen HM, de Vries ACH, van der Lely AJ, van den Heuvel-Eibrink MM, Neggers SJCMM. Bolier M, et al. Among authors: van der pal hj. Eur J Endocrinol. 2024 Nov 27;191(6):588-603. doi: 10.1093/ejendo/lvae149. Eur J Endocrinol. 2024. PMID: 39564675
Healthcare providers' expected barriers and facilitators to the implementation of person-centered long-term follow-up care for childhood cancer survivors: A PanCareFollowUp study.
Breij D, Hjorth L, Bouwman E, Walraven I, Kepak T, Kepakova K, Haupt R, Muraca M, Göttgens I, Stollman I, Winther JF, Kienesberger A, Gsell H, Michel G, Blijlevens N, Pluijm SMF, Roser K, Skinner R, Renard M, Uyttebroeck A, Follin C, van der Pal HJH, Kremer LCM, Loonen J, Hermens R; PanCareFollowUp Consortium. Breij D, et al. Among authors: van der pal hjh. Cancer Med. 2024 Oct;13(20):e70225. doi: 10.1002/cam4.70225. Cancer Med. 2024. PMID: 39440690 Free PMC article.
Risk and Protective Factors of Psychosocial Functioning in Survivors of Childhood Cancer: Results of the DCCSS-LATER Study.
Maas A, Maurice-Stam H, Feijen EAML, Teepen JC, van der Aa-van Delden AM, Streefkerk N, van Dulmen-den Broeder E, Tissing WJE, Loonen JJ, van der Pal HJH, de Vries ACH, van den Heuvel-Eibrink MM, Ronckers C, Neggers S, Bresters D, Louwerens M, Versluys BAB, van der Heiden-van der Loo M, Kremer LCM, Grootenhuis M; DCCSS‐LATER Study Group. Maas A, et al. Among authors: van der pal hjh. Psychooncology. 2024 Oct;33(10):e9313. doi: 10.1002/pon.9313. Psychooncology. 2024. PMID: 39358839
Long-Term Risk of Subsequent Neoplasms in 5-Year Survivors of Childhood Neuroblastoma: A Dutch Childhood Cancer Survivor Study-LATER 3 Study.
Westerveld ASR, Tytgat GAM, van Santen HM, van Noesel MM, Loonen J, de Vries ACH, Louwerens M, Koopman MMW, van der Heiden-van der Loo M, Janssens GO, de Krijger RR, Ronckers CM, van der Pal HJH, Kremer LCM, Teepen JC. Westerveld ASR, et al. Among authors: van der pal hjh. J Clin Oncol. 2024 Oct 2:JCO2301430. doi: 10.1200/JCO.23.01430. Online ahead of print. J Clin Oncol. 2024. PMID: 39356982
211 results